Consent to the Distribution of Changed Medicines Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Moclobemide 100 mg, 150 mg, 300 mg Tablets F Hoffmann-La Roche Limited, Basle, Switzerland Aurorix Itraconazole 100 mg Capsule Janssen Pharmaceutica n.v., Belgium Sporanox Foscarnet trisodium hexahydrate 24 mg/ml in 250 ml and 500 ml Intravenous solution for infusion Astra Pharmaceuticals Production AB., Sodertalje, Sweden and Netherlands Produktielaboratotium voor Bloedtransfusieapparatuur en Infusievloeistoffen B.V., Emmer-Compascuum, The Netherlands Foscavir Cefpodoxime proxetil 52.18 mg equivalent to 40 mg/5 ml when reconstituted with water Granules for suspension (oral) Usiphar Production Unit, Compeigne, France Orelox Dated this 27th day of June 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1994.